Skip to main navigation Skip to search Skip to main content

A Double-blind, Placebo-controlled, Randomized Withdrawal Study of Lurasidone for the Maintenance Treatment of Subjects with Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date01/3/12 → 07/2/14

Funding

  • Sunovion Pharmaceuticals Incorporated: $43,813.55